Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Mitrou

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
MMW, Munchener Medizinische Wochenschrift|December 2, 1983
[Acquired immunodeficiency syndrome (AIDS) in male homosexuals in Frankfurt am Main]E B Helm, L Bergmann, M Elbert, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trialP S Mitrou, M Graubner, W E Berdel, et al.
Leukemia Research|February 1, 1995
Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicityB Jahn, L Bergmann, E Weidmann, et al.
Leukemia & Lymphoma|August 1, 1995
Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomasK Fenchel, L Bergmann, P Wijermans, et al.
Onkologie|April 1, 1990
Interleukin-2 in combination with interferon-alpha in disseminated malignant melanoma and advanced renal cell carcinoma. A phase I/II studyL Bergmann, E Weidmann, P S Mitrou, et al.
Leukemia|May 1, 1997
Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501E Weidmann, J Brieger, T Karakas, et al.
Leukemia & Lymphoma|December 1, 1996
Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomasT Karakas, L Bergmann, H J Stutte, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 1987
[The effect of radio- and chemotherapy on survival in advanced head and neck tumors]A Klima, C von Ilberg, L Bergmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II studyM J Rummel, G Käfer, M Pfreundschuh, et al.
Leukemia & Lymphoma|January 1, 1995
Interleukin-2 bolus infusion as late consolidation therapy in 2nd remission of acute myeloblastic leukemiaL Bergmann, G Heil, K Kolbe, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
MMW, Munchener Medizinische Wochenschrift|December 2, 1983
[Acquired immunodeficiency syndrome (AIDS) in male homosexuals in Frankfurt am Main]E B Helm, L Bergmann, M Elbert, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1984
cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trialP S Mitrou, M Graubner, W E Berdel, et al.
Leukemia Research|February 1, 1995
Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicityB Jahn, L Bergmann, E Weidmann, et al.
Leukemia & Lymphoma|August 1, 1995
Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomasK Fenchel, L Bergmann, P Wijermans, et al.
Onkologie|April 1, 1990
Interleukin-2 in combination with interferon-alpha in disseminated malignant melanoma and advanced renal cell carcinoma. A phase I/II studyL Bergmann, E Weidmann, P S Mitrou, et al.
Leukemia|May 1, 1997
Establishment and characterization of a new, factor-independent acute myeloid leukemia line designated Ei501E Weidmann, J Brieger, T Karakas, et al.
Leukemia & Lymphoma|December 1, 1996
Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomasT Karakas, L Bergmann, H J Stutte, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 1987
[The effect of radio- and chemotherapy on survival in advanced head and neck tumors]A Klima, C von Ilberg, L Bergmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II studyM J Rummel, G Käfer, M Pfreundschuh, et al.
Leukemia & Lymphoma|January 1, 1995
Interleukin-2 bolus infusion as late consolidation therapy in 2nd remission of acute myeloblastic leukemiaL Bergmann, G Heil, K Kolbe, et al.
Pageof 11